Literature DB >> 28224362

Analysis of FOXP3+ regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus.

Angelika Schmidt1,2, Cosima C Rieger1,3, Ram Kumar Venigalla4,5, Szabolcs Éliás2, Regina Max4, Hanns-Martin Lorenz4, Hermann-Josef Gröne6, Peter H Krammer1, Annegret Kuhn7,8.   

Abstract

Regulatory T cells (Tregs) are critical mediators of immune tolerance, yet their involvement in the autoimmune disease systemic lupus erythematosus (SLE) is incompletely understood. We analyzed CD4+ T cell subpopulations with Treg-related phenotypes and their association with disease activity in peripheral blood (PB) and tissues of patients with SLE. In detail, we quantified subpopulations regarding CD25, FOXP3, CD62L, CCR6, CD27, CD45RA, and CD45RO expression in PB from 31 patients with SLE divided into two disease activity groups and 32 healthy controls using flow cytometry. CD4+ and FOXP3+ T cells in skin and kidney biopsies of patients with SLE were quantified by immunohistochemistry. CD4+CD25+/++FOXP3+ and CD4+CD25+CD45RA-/CD45RO+ T cell frequencies were significantly higher in PB from patients with active compared to inactive SLE. The fraction of CD4+CD25++FOXP3+ Tregs and CD4+CD25+CD45RA+/CD45RO- naïve Tregs was not significantly different between these groups. CD4+CD25++ Tregs from active SLE patients comprised significantly less CD27+ cells and more CCR6+ cells compared to patients with inactive SLE. The percentage of CD4+FOXP3+ T cells among inflammatory infiltrates in skin and kidney biopsies of SLE patients was not different from other inflammatory skin/kidney diseases. In conclusion, although CD4+FOXP3+ T cell frequencies in the inflamed tissues of SLE patients were comparable to other inflammatory diseases, distinct T cell subpopulations appeared misbalanced in PB of patients with active SLE. Here, cells phenotypically resembling activated T cells, but not Tregs, were increased compared to patients with inactive SLE. Within Tregs of patients with active SLE, markers related to Treg function and homing were altered.

Entities:  

Keywords:  Autoimmune diseases; FOXP3; Regulatory T cells; Systemic lupus erythematosus (SLE)

Mesh:

Substances:

Year:  2017        PMID: 28224362     DOI: 10.1007/s12026-017-8904-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  49 in total

1.  CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset.

Authors:  Markus Kleinewietfeld; Fabiola Puentes; Giovanna Borsellino; Luca Battistini; Olaf Rötzschke; Kirsten Falk
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

2.  Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity.

Authors:  Vinodh Pillai; Nitin J Karandikar
Journal:  Blood       Date:  2008-01-01       Impact factor: 22.113

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 4.  Control of tissue-localized immune responses by human regulatory T cells.

Authors:  Anne M Pesenacker; Raewyn Broady; Megan K Levings
Journal:  Eur J Immunol       Date:  2014-12-08       Impact factor: 5.532

Review 5.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

6.  Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.

Authors:  H-Y Lee; Y-K Hong; H-J Yun; Y-M Kim; J-R Kim; W-H Yoo
Journal:  Rheumatology (Oxford)       Date:  2008-04-03       Impact factor: 7.580

7.  CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.

Authors:  Sandra Klein; Cosima C Kretz; Peter H Krammer; Annegret Kuhn
Journal:  J Invest Dermatol       Date:  2009-11-26       Impact factor: 8.551

Review 8.  FOXP3 and scurfy: how it all began.

Authors:  Fred Ramsdell; Steven F Ziegler
Journal:  Nat Rev Immunol       Date:  2014-04-11       Impact factor: 53.106

9.  CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study.

Authors:  Konstantinos Tselios; Alexandros Sarantopoulos; Ioannis Gkougkourelas; Panagiota Boura
Journal:  Clin Exp Rheumatol       Date:  2014-09-08       Impact factor: 4.473

10.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

View more
  7 in total

1.  Editorial: Cutting edge in systemic lupus erythematosus.

Authors:  David P D'Cruz; Annegret Kuhn
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 2.  Modulation of the Immune System for the Treatment of Glaucoma.

Authors:  Katharina Bell; Nadine von Thun Und Hohenstein-Blaul; Julia Teister; Franz Grus
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

3.  Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome.

Authors:  Xinlin Xiong; Zhenhua Luo; Haiyan Zhou; Zonggang Duan; Li Niu; Kai Zhang; Guangwei Huang; Wei Li
Journal:  J Inflamm Res       Date:  2022-02-22

Review 4.  Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges.

Authors:  Tapas Kumar Goswami; Mithilesh Singh; Manish Dhawan; Saikat Mitra; Talha Bin Emran; Ali A Rabaan; Abbas Al Mutair; Zainab Al Alawi; Saad Alhumaid; Kuldeep Dhama
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

5.  CCR6+ Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status.

Authors:  Wei Zhong; Zhenyu Jiang; Jiang Wu; Yanfang Jiang; Ling Zhao
Journal:  PeerJ       Date:  2018-02-09       Impact factor: 2.984

Review 6.  Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

Authors:  Masayuki Mizui; George C Tsokos
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

7.  New biomarkers in SLE: from bench to bedside.

Authors:  Riccardo Capecchi; Ilaria Puxeddu; Federico Pratesi; Paola Migliorini
Journal:  Rheumatology (Oxford)       Date:  2020-12-05       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.